Penny Stocks To Buy [Or Avoid] #4 Onconova Therapeutics
Another penny stock that made an interesting move on Friday was Onconova Therapeutics (ONTX – Free Report). It rallied by as much as 68% last week owing to an announcement from the company earlier on in the week. Onconova reported that it’s Chief Executive Officer and President, Dr. Steven M. Fruchtman, is also going to make a presentation at the BIO CEO & Investor Conference in New York City.
In addition to that, it has also been revealed that the company’s CEO and other executives will also be available for one on one meetings. Unlike Oragenics, Onconova presents Tuesday afternoon (February 11). Next week, the company extends its presentation schedule with an appearance at NobleCon16.
On February 17th CEO Dr. Steven Fruchtman will give a company update at the conference. Investors could keep an eye on ONTX stock not only this week considering the BIO CEO conference but also into next week ahead of NobleCon16.
